Consensus on renal cortical scintigraphy in children with urinary tract infection1

https://doi.org/10.1016/S0001-2998(99)80006-3Get rights and content

A questionnaire related to cortical scintigraphy in children with urinary tract infection was submitted to 30 experts. A wide consensus was reached on several issues related to planar images: 99mTc dimercapto succinic acid (DMSA) appears as the most appropriate tracer for renal imaging; dynamic tracers are considered to be inferior, in particular 99mTc diethylenetriaminepentaacetate, which is not recommended. The general opinion is that DMSA scintigraphy is not feasible with a minimal dose below 15 MBq, whereas the maximum dose should not be higher than 110 MBq. The dose schedule generally is based on body surface area, and sedation is only exceptionally given to children. Images are obtained 2 to 3 hours after injection, preferably with high resolution collimators; pinhole images are used by only half of the experts. Posterior and posterior oblique views are used by most of the experts, and the posterior view is acquired in supine positions. At least 200.000 kcounts or 5 minute acquisition is required for nonzoomed images. As a quality control, experts check the presence of blurred or double outlines on the DMSA images. Color images are not used and experts report on film or directly on the computer screen. As far as normal DMSA images are concerned, most experts agree on several normal variants. Hydronephrosis is not a contraindication for DMSA scintigraphy but constitutes a pitfall. Differential renal function generally is measured, but no consensus is reached whether or not background should be subtracted. Most of the experts consider 45% as the lowest normal value. A consensus is reached on some scintigraphic aspects that are likely to improve and on some others that probably represent persistent sequelae. There is a wide consensus for the systematic use of DMSA scintigraphy for detection of renal sequelae, whereas only 58% of the experts are systematically performing this examination during the acute phase of infection.

References (125)

  • MajdM et al.

    Relationship among vesicoureteral reflux, P-fimbriated Escherichia coli and acute pyelonephritis in children with febrile urinary tract infection

    J Pediatr

    (1991)
  • RushtonHG

    Renal scarring following pyelonephritis

    J Urol

    (1992)
  • RisdonRA et al.

    Renal pathology and the Tc-99m DMSA image during the evolution of early pyelonephritic scar: an experimental study

    J Urol

    (1994)
  • RushtonHG et al.

    Evaluation of Tc-99m DMSA renal scans in experimental acute pyelonephritis in piglets

    J Urol

    (1988)
  • GiblinJG et al.

    The diagnosis of acute pyelonephritis in the piglet using single photon emission computerized tomography DMSA scintigraphy: a pathological correlation

    J Urol

    (1993)
  • PiepszA

    Recent advances in pediatric nuclear medicine

    Semin Nucl Med

    (1995)
  • MajdM et al.

    Renal cortical scintigraphy in the diagnosis of acute pyelonephritis

    Semin Nucl Med

    (1992)
  • EggliDF et al.

    Scintigraphic evaluation of pediatric urinary tract infection

    Semin Nucl Med

    (1993)
  • RosenbergAR et al.

    Evaluation of acute urinary tract infection in children by DMSA scintigraphy: a prospective study

    J Urol

    (1992)
  • Mc AfeeJG et al.

    Visualisation of renal parenchyma: scintigram with 203 Hg neohydrin

    Radiology

    (1960)
  • RaynaudC et al.

    Measuring renal uptake of HgC12-197 by gamma camera

    Radiology

    (1974)
  • de KievitW

    Technetium radiopharmaceuticals: chemical characterization and tissue distribution of Tc-Glucoheptonate using Tc-99m and carrier Tc-99

    J Nucl Med

    (1981)
  • TraismanES et al.

    The localization of urinary tract infection with Tc-99m glucoheptonate scintigraphy

    Pediatr Radiol

    (1986)
  • StyJR et al.

    Imaging in acute renal infection in children

    AJR

    (1987)
  • LinTH et al.

    A Tc-99m chelate substitute for organomercurial renal agents

    J Nucl Med

    (1974)
  • EnlanderD et al.

    Renal cortical imaging in 35 patients, superior quality with Tc-99m DMSA

    J Nucl Med

    (1974)
  • EvansK et al.

    Biokinetic behavior of Tc-99m DMSA in children

    J Nucl Med

    (1996)
  • PetersAM et al.

    Two routes for Tc-99m DMSA uptake into the renal cortical tubular cell

    Eur J Nucl Med

    (1988)
  • De LangeMJ et al.

    Renal handling of Tc-99m DMSA: evidence for glomerular filtration and peritubuluar uptake

    J Nucl Med

    (1989)
  • Müller SuurR et al.

    No evidence for tubular reabsorption of DMSA

    Eur J Nucl Med

    (1994)
  • QuinnRJ et al.

    Poor technetium-99m DMSA renal uptake caused by tubulointerstitial renal disease

    J Nucl Med

    (1991)
  • HechtH et al.

    Poor renal uptake of Tc-99m DMSA and near-normal Tc-99m MAG3 renogram in nephronophtisis

    Pediatr Nephrol

    (1996)
  • HandmakerH et al.

    Clinical experience with Tc-99m DMSA: a new renal-imaging agent

    J Nucl Med

    (1975)
  • PiepszA et al.

    Tc-99m DMSA imaging and the obstructed kidney

    Clin Nucl Med

    (1986)
  • WujantoR et al.

    Assessment of renal function and scarring: is a DMSA scan always necessary?

  • GordonI et al.

    Can Tc-99m Mercaptoacetyltriglycine replace Tc-99m DMSA in the exclusion of a focal renal defect?

    J Nucl Med

    (1992)
  • PiepszA et al.

    Replacing Tc-99m DMSA for renal imaging?

    Nucl Med Comm

    (1992)
  • YardiÖF et al.

    Comparison of Tc-99m DMSA and cortical phase summed images of Tc-99m EC in evaluation of split renal function and renal cortical diseases (abstract)

    Eur J Nucl Med

    (1997)
  • SmithT et al.

    Radiation dosimetry of Tc-99m DMSA in children

    J Nucl Med

    (1996)
  • SmithT et al.

    Comparison of radiation dose from intravenous urography and Tc-99m DMSA scintigraphy in children

    Br J Radiol

    (1998)
  • PiepszA et al.

    A radiopharmaceutical schedule for imaging in paediatrics

    Eur J Nucl Med

    (1990)
  • AlménA et al.

    The radiation dose to children from X-ray examinations of the pelvis and the urinary tract

    Br J Radiol

    (1995)
  • VestergrenE

    Administered activity of Tc-99m DMSA for kidney scintigraphy in children

    Nucl Med Commun

    (1998)
  • MerrickMV et al.

    The detection of pyelonephritic scarring in children by radioisotopic imaging

    Br J Radiol

    (1980)
  • BinghamJB et al.

    An evaluation of the use of Tc99m DMSA as a static renal imaging agent

    Br J Radiol

    (1978)
  • BjorgvinssonE et al.

    Diagnosis of acute pyelonephritis in children: comparison of sonography and Tc-99m DMSA scintigraph

    Am J Roentgenol

    (1991)
  • MelisK et al.

    Involvement of the renal parenchyma in acute urinary tract infection: the contribution of Tc-99m DMSA scan

    Eur J Pediatr

    (1992)
  • JakobssonB et al.

    Tc-99m DMSA scan in the diagnosis of acute pyelonephritis in children: relation to clinical and radiological findings

    Pediatr Nephrol

    (1992)
  • VerberIG et al.

    Development of renal scars after acute nephronia in childhood: a study of sequential DMSA scans

  • TappinDM et al.

    A prospective study of children with first acute symptomatic E. coli urinary tract infection. Early Tc-99m DMSA scan appearances

    Acta Paediatr Scand

    (1989)
  • Cited by (168)

    • ACR Appropriateness Criteria<sup>®</sup> Urinary Tract Infection—Child

      2017, Journal of the American College of Radiology
    View all citing articles on Scopus
    1

    With the participation of the following experts: B. Bagni, Italy; M. Gelfand, USA; N. Goldraich, Brazil; D. Groshar, Israël; R. Howman-Giles, Australia; B. Jakobsson, Sweden; E. Jacsic, Yugoslavia; N. Karatzas, Greece; J. Le Cloirec, France: R. Mackenzie, UK; G. Mandell, USA; M.D. Mann, South Africa; K. Melis, Belgium; M.V. Merrick, UK; H. Nadel, Canada; C. Reiners, Germany; I. Roca, Spain; D.B. Schere, Argentina; G. Sfakianakis, USA; D.O. Slosman, Switzerland; S. Treves, USA; L. Wallin, Sweden.

    View full text